DermTech (DMTK) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free DMTK Stock Alerts $0.59 -0.03 (-4.87%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDermTech (NASDAQ:DMTK) Rating Reiterated by Stephensamericanbankingnews.com - April 21 at 5:56 AMLake Street Capital Reiterates "Hold" Rating for DermTech (NASDAQ:DMTK)americanbankingnews.com - April 21 at 5:22 AMDermTech (NASDAQ:DMTK) Stock Rating Reaffirmed by BTIG Researchamericanbankingnews.com - April 21 at 4:36 AMDermTech stock downgraded by BTIG amid strategic reviewinvesting.com - April 20 at 8:46 PMBTIG Downgrades DermTech (DMTK)msn.com - April 19 at 11:29 PMWhat Analysts Are Saying About DermTech Stockmarkets.businessinsider.com - April 19 at 1:29 PMDermTech to Slash 56% of Workforce, Explore Optionsmarketwatch.com - April 18 at 8:56 PMDermTech exploring strategic alternatives, cutting 56% of staffmsn.com - April 18 at 8:56 PMDermTech to Explore Strategic Alternatives and Implement Restructuring Planbusinesswire.com - April 18 at 4:15 PMDermTech, Inc. (DMTK)finance.yahoo.com - April 17 at 6:34 PMDermTech (NASDAQ:DMTK) Trading Down 0.9%americanbankingnews.com - April 17 at 2:20 AMDermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatologybusinesswire.com - March 8 at 8:05 AMStephens cuts DermTech stock target to $1.50, keeps Equal Weight ratinginvesting.com - March 7 at 10:18 AMDermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 9:48 AMRecap: DermTech Q4 Earningsbenzinga.com - February 29 at 6:05 PMDermTech Reports Fourth-Quarter 2023 Financial Resultsbusinesswire.com - February 29 at 4:01 PMDermTech Q4 2023 Earnings Previewmsn.com - February 28 at 9:12 PMDermTech Announces Release Date for Fourth-quarter 2023 Financial Resultsfinance.yahoo.com - February 13 at 12:52 PMDermTech International Registered Shsmarkets.businessinsider.com - February 1 at 10:27 AMDermTech to Cut Workforce by 15%, Six Months After Round of Layoffsmarketwatch.com - January 31 at 6:32 PMDermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operationsfinance.yahoo.com - January 31 at 6:32 PMDermTech study finds melanoma test effective for all skin typesmsn.com - January 18 at 4:01 PMDermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Typesfinance.yahoo.com - January 18 at 9:27 AMDermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assayfinance.yahoo.com - January 16 at 10:25 AMDermTech Shares Rise 14% After Positive Results in Melanoma Test Studymarketwatch.com - January 8 at 3:46 PMDermTech stock rallies 18% on positive study for melanoma testseekingalpha.com - January 8 at 10:45 AMDermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)finance.yahoo.com - January 8 at 10:45 AMDermTech Stock (NASDAQ:DMTK) Dividends: History, Yield and Datesbenzinga.com - January 3 at 7:27 AMDERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firmbusinesswire.com - December 29 at 3:07 AMDMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action ...businesswire.com - December 15 at 4:10 PMThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DermTech, Inc. (DMTK)businesswire.com - December 14 at 11:17 AMDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the ...businesswire.com - December 13 at 1:47 AMINVESTOR ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuitmarkets.businessinsider.com - December 13 at 1:47 AMDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firmfinancialpost.com - December 12 at 10:06 PMDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firmbusinesswire.com - December 12 at 9:08 PMDermTech Ongoing Deadline Alertmarkets.businessinsider.com - December 12 at 8:47 PMIMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the Firmbarrons.com - December 11 at 10:01 AMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of DermTech, Inc. (DMTK) of a Class Action Lawsuit and an Upcoming Deadlinebarrons.com - December 7 at 11:41 AMDermTech Deadline Alertstockhouse.com - December 6 at 9:24 PMROSEN, A RANKED AND LEADING FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKbarrons.com - December 2 at 4:32 PMROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMTKbenzinga.com - November 29 at 8:26 PMDMTK Investor Alert: Bronstein, Gewirtz & Grossman LLC Reminds DermTech, Inc. Investors with Substantial Losses to Contact the Firm!barrons.com - November 29 at 3:25 PMLawsuit Deadline Alert: Investors who lost over $100,000 with shares of DermTech, Inc. (NASDAQ: DMTK) should contact the Shareholders Foundationbenzinga.com - November 28 at 6:38 PMSHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuitmarkets.businessinsider.com - November 26 at 3:43 PMDMTK Investors Have Opportunity to Lead DermTech, Inc. Securities Fraud Lawsuitbenzinga.com - November 22 at 8:28 PMSHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuitmarkets.businessinsider.com - November 22 at 3:28 PMDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses of $100,000 to Contact the Firmbarrons.com - November 22 at 10:27 AMROSEN, NATIONAL TRIAL LAWYERS, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKmarkets.businessinsider.com - November 21 at 12:51 AMINVESTOR ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuitmarkets.businessinsider.com - November 20 at 9:37 AMROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKbenzinga.com - November 17 at 8:34 PM Get DermTech News Delivered to You Automatically Sign up to receive the latest news and ratings for DMTK and its competitors with MarketBeat's FREE daily newsletter. Email Address The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! DMTK Media Mentions By Week DMTK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DMTK News Sentiment▼-0.060.38▲Average Medical News Sentiment DMTK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DMTK Articles This Week▼92▲DMTK Articles Average Week Get DermTech News Delivered to You Automatically Sign up to receive the latest news and ratings for DMTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Exagen News Centogene News Psychemedics News BioNexus Gene Lab News OpGen News Renalytix News Enzo Biochem News Personalis News MEI Pharma News Nephros News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DMTK) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DermTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
